Investigation of the Efficiency of Different Exercise Approaches in Individuals Providing Primary Care to Multiple Sclerosis Patients

CompletedNot a drug-phase studyMS (type not specified)NCT05896995

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

This trial finished 3 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Pilates Exercise

Compared with

  • Mckenzie Exercise

What it measured

Main measures

  • Oswestry Low Back Pain Disability Questionnaire

    6 weeks

    Walking and mobilityBladder, bowel and sexual functionPainMood and sleepQuality of life (reported by participants)
  • Beck Depression Scale

    6 weeks

    FatigueMood and sleepQuality of life (reported by participants)
  • Bakas Caregiver Impact Scale.

    6 weeks

  • Disability status assessment.

    6 weeks

    Disability progression
  • Multiple Sclerosis Quality of Life-54 (MSQOL-54)

    6 weeks

    FatigueBladder, bowel and sexual functionPainQuality of life (reported by participants)
  • Algometer

    6 weeks

    Pain

Who could take part

MS (type not specified) · 18 to 65

Show the full criteria

Inclusion criteria

* Chronic low back pain he is 18-60 years old * No verbal communication barrier * Complaining of pain for more than three months * Volunteering of participants Exclusion Criteria * Absence of cognitive impairment (delirium, dementia, amnesia) * Exercise contraindications (uncontrolled medical conditions) * Caring for individuals with an unclear diagnosis of MS * Disagreeing with the measurements to be made or providing incomplete answers * Previous spinal surgery * Spinal and joint disorders other than lumbar disc herniation

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Multiple Sclerosis is known as an inflammatory central nervous system disease characterized by demyelination and axonal damage.

Loading reviews and guidelines…

History

    1. Started

      May 2023

    2. Main results due

      Jun 2023

    3. Finished

      Jul 2023

    Assembled by software from public sources.